| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 02/06/2002 | EP1177785A2 Growth promoting pharmaceutical implant |
| 02/06/2002 | EP1177729A2 Pharmaceutical and food compositions containing "wood alcohols" or "wood sterols" useful for lowering serum cholesterol |
| 02/06/2002 | EP1177445A1 Methods for screening gaba-modulatory compounds for specified pharmacological activities |
| 02/06/2002 | EP1177435A1 Non-mammalian transgenic animal having an adult onset neurodegenerative phenotype |
| 02/06/2002 | EP1177296A2 Extracellular matrix and adhesion-associated proteins |
| 02/06/2002 | EP1177295A1 Ox2 receptor homologs |
| 02/06/2002 | EP1177293A1 Growth factor homolog zvegf4 |
| 02/06/2002 | EP1177286A1 Mdm interacting protein and methods of use thereof |
| 02/06/2002 | EP1177190A2 USE OF SELECTIVE ANTAGONISTS OF THE ALPHA 1b-ADRENERGIC RECEPTOR FOR IMPROVEMENT OF SEXUAL DYSFUNCTION |
| 02/06/2002 | EP1177016A2 Composition and method for preventing/reducing the severity of side effects of chemotherapy and/or radiation therapy |
| 02/06/2002 | EP1176981A1 Treatment of autoimmune diseases with antagonists which bind to b cell surface markers |
| 02/06/2002 | EP1176980A1 Ccr4 antagonists in sepsis |
| 02/06/2002 | EP1176974A1 Compositions and methods for treating benign prostatic hyperplasia using tocotrienols |
| 02/06/2002 | EP1176972A1 Use of phyllanthus for targeted stimulation of the immune system |
| 02/06/2002 | EP1176971A1 Use of phyllanthus for treating chronically inflammatory and fibrotic processes |
| 02/06/2002 | EP1176967A1 Management of pain after joint surgery |
| 02/06/2002 | EP1176966A2 Oligodeoxynucleotide and its use to induce an immune response |
| 02/06/2002 | EP1176963A2 Use of dopamine d 3? receptor ligands for producing medicaments for treating kidney disorders |
| 02/06/2002 | EP1176960A1 Synergistic combination comprising roflumilast and a pde-3 inhibitor |
| 02/06/2002 | EP1176957A1 Method for treating abnormal cell proliferation in the brain |
| 02/06/2002 | EP1176951A1 Drug delivery device |
| 02/06/2002 | EP1176948A1 Anti-nausea compositions and methods |
| 02/06/2002 | EP1176877A1 Methods for lowering viscosity of glucomannan compositions |
| 02/06/2002 | EP1176871A1 Novel beta-secretase and modulation of beta-secretase activity |
| 02/06/2002 | EP1030677B1 Synergetic oral composition combining salmon dna with hydroxyproline |
| 02/06/2002 | EP1021200B1 Methods and compositions for treating rheumatoid arthritis |
| 02/06/2002 | EP1019802A4 Method and system for pain management |
| 02/06/2002 | EP0938330B1 Use of lh-rh antagonists as diagnostic agent |
| 02/06/2002 | EP0882024B1 Retroviral protease inhibiting compounds |
| 02/06/2002 | EP0855908B1 Dietary regimen of nutritional supplements for relief of symptoms of arthritis |
| 02/06/2002 | EP0777487B1 Treatment of stroke associated with macrophage infiltration |
| 02/06/2002 | EP0764028B1 Method of treating retained pulmonary secretions |
| 02/06/2002 | EP0731694B1 Opioid formulations for treating pain |
| 02/06/2002 | EP0730448B1 Use of nitric oxide synthase substrate and/or donor, or a nitric oxide inhibitor for the manufacture of medicaments for the treatment of uterine contractility disorders |
| 02/06/2002 | EP0688219B1 Reduction of boar odor in meat |
| 02/06/2002 | EP0659082B1 Use of cytochrome p450 inhibitors for inhibiting the metabolism of nitrogen substituted acridine |
| 02/06/2002 | CN1334875A Cell signalling polypeptides and nucleic acids |
| 02/06/2002 | CN1334820A Connective tissue growth factor fragments and methods and uses thereof |
| 02/06/2002 | CN1334819A Connective tissue growth factor fragments and methods and uses thereof |
| 02/06/2002 | CN1334814A Antiviral nucleoside analogues |
| 02/06/2002 | CN1334807A 1-heterocycle substd. diarylamines |
| 02/06/2002 | CN1334731A Pharmaceutical formulation |
| 02/06/2002 | CN1334730A Vitronectin receptor antagonist |
| 02/06/2002 | CN1334727A Method and composition for treating and preventing tuberculosis |
| 02/06/2002 | CN1334122A Medicine for treating HIV infection, its composition and its use |
| 02/05/2002 | US6344481 Thyromimetic antiobesity agents |
| 02/05/2002 | US6344478 Mixture with carbonic anhydrase inhibitor |
| 02/05/2002 | US6344475 Cystic fibrosis |
| 02/05/2002 | US6344474 Use of central cannabinoid receptor antagonists for regulating appetence |
| 02/05/2002 | US6344470 Aminothiazole derivatives, method of preparation and pharmaceutical compositions containing same |
| 02/05/2002 | US6344461 Treating skin wrinkles/fine lines with calcium channel inhibitors |
| 02/05/2002 | US6344450 Lactam compounds and their use as inhibitors of serine proteases and method |
| 02/05/2002 | US6344447 Administering mixture of nucleosides; anticancer agent |
| 02/05/2002 | US6344441 Lipoprotein-regulating medicaments |
| 02/05/2002 | US6344438 Therapeutic/cosmetic compositions comprising CGRP antagonists for treating the eyes or eyelids |
| 02/05/2002 | US6344358 Administering somatostatin releasing agent to treat brain, psychological and nervous system disorders such as schizophrenia, amnesia, bipolar disorder, alzheimer*s disease and parkinson*s disease |
| 02/05/2002 | US6344210 Composition for freshening nostrils and sinus cavities |
| 02/05/2002 | US6344189 Topical administration of a serine protease inhibitor, such as pai-2. |
| 02/05/2002 | US6344181 Decreased endogenous nitric oxide activation |
| 02/05/2002 | CA2218289C Cd45rb binding compounds for the prevention of transplant rejection |
| 02/05/2002 | CA2150714C Syndecan stimulation of cellular differentiation |
| 02/05/2002 | CA2110993C Food composition for inhibiting the formation of an intestinal putrefactive product |
| 02/05/2002 | CA2078578C Medical use for tachykinin antagonists |
| 02/05/2002 | CA2045290C Plaster with a high content of softening ingredients |
| 02/05/2002 | CA2006473C Improved anti-infective therapy |
| 02/03/2002 | CA2353364A1 Aerosol for the treatment or prevention of pain |
| 02/01/2002 | WO2001007617A1 Human homologue of bovine neuroendocrine secretory protein, nesp55, polynucleotides and uses thereof linked with obesity |
| 02/01/2002 | CA2380942A1 Human homologue of bovine neuroendocrine secretory protein, nesp55, polynucleotides and uses thereof linked with obesity |
| 01/31/2002 | WO2002008449A2 Ho-1 suppressor as a diagnostic and prognostic test for dementing diseases |
| 01/31/2002 | WO2002008407A2 Gene-targeted non-human mammal with human fad presenilin mutation and generational offspring |
| 01/31/2002 | WO2002008399A2 Human kinases |
| 01/31/2002 | WO2002008396A2 Human proteases |
| 01/31/2002 | WO2002008292A2 Human monoclonal antibody against hepatitis c virus e2 glycoprotein |
| 01/31/2002 | WO2002008291A2 Multi-specific reagent for selective stimulation of cell surface receptors |
| 01/31/2002 | WO2002008285A2 Il-17 molecules and uses thereof |
| 01/31/2002 | WO2002008284A2 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis |
| 01/31/2002 | WO2002008271A1 Novel fibroblast growth factor (fgf23) and methods for use |
| 01/31/2002 | WO2002008256A2 Peptides as ns3-serine protease inhibitors of hepatitis c virus |
| 01/31/2002 | WO2002008255A2 Cell cycle proteins and mitosis-associated molecules |
| 01/31/2002 | WO2002008244A2 Peptides as ns3-serine protease inhibitors of hepatitis c virus |
| 01/31/2002 | WO2002008226A2 Tricyclic 2-pyridone compounds useful as hiv reverse transcriptase inhibitors |
| 01/31/2002 | WO2002008213A1 Colchinol derivatives as angiogenesis inhibitors |
| 01/31/2002 | WO2002008198A2 Novel imidazolidinones as ns3-serine protease inhibitors of hepatitis c virus |
| 01/31/2002 | WO2002008187A1 Novel peptides as ns3-serine protease inhibitors of hepatitis c virus |
| 01/31/2002 | WO2002008178A1 New combination of serotonin agonist (5ht2) and antagonist (5ht6)as pharmaceutical formulation |
| 01/31/2002 | WO2002007821A1 Method for locating compounds which are suitable for the treatment and/or prophylaxis of obesity |
| 01/31/2002 | WO2002007777A1 USE OF THE INTERFERON RECEPTOR 2c POLYPEPTIDE CHAIN TO ENHANCE THE ANTI-GROWTH EFFECTS OF TYPE I INTERFERONS |
| 01/31/2002 | WO2002007773A2 Multi-component biological transport systems |
| 01/31/2002 | WO2002007770A2 Polymeric conjugates of antitumor agents |
| 01/31/2002 | WO2002007765A2 REGULATORS OF PPARδ(β) AND THEIR USE IN THE TREATMENT OF OBESITY AND INSULIN RESISTANCE |
| 01/31/2002 | WO2002007753A2 Method for treating unstable angina pectoris |
| 01/31/2002 | WO2002007748A2 Stimulation of cartilage growth with agonists of the non-proteolytically activated thrombin receptor |
| 01/31/2002 | WO2002007734A1 Compositions and methods of preventing or reducing the risk or incidence of skeletal injuries in horses |
| 01/31/2002 | WO2002007730A1 Alpha v integrin receptor antagonists |
| 01/31/2002 | WO2002007728A1 Hair loss prevention |
| 01/31/2002 | WO2002007721A2 Use of cox-2 inhibitors for preventing immunodeficiency |
| 01/31/2002 | WO2002007717A1 Emulsion of perfluororganic compounds for medical purposes, method for producing said emulsion and methods for curing and preventing diseases with the aid of the emulsion |
| 01/31/2002 | WO2002007712A2 Self-emulsifying drug delivery systems for extremely water-insoluble, lipophilic drugs |
| 01/31/2002 | WO2002007673A2 Calcilytic compounds |
| 01/31/2002 | WO2002007531A1 Dietary lipids for improving skin and coat of pets |